[ Price : $8.95]
HHS restores FDAs authority to issues regulations without HHS authority, which was removed late in the Trump Administration.[ Price : $8.95]
FDA accepts for review a Supernus Pharmaceuticals supplemental NDA for Qelbree (viloxazine extended-release capsules) for treating...[ Price : $8.95]
FDA clears a Molekule 510(k) for its existing air purifier, Air Pro, classifying it as a Class 2 medical device for medical use fo...[ Price : $8.95]
Federal Register notice: FDA renews its National Mammography Quality Assurance Advisory Committee for an additional two years beyo...[ Price : $8.95]
FDA cautions that it may only be able to give the green light for booster shots later this month to those vaccinated with the Pfiz...[ Price : $8.95]
CDER Office of Generic Drugs reaches the milestone of approving more than 100 generic drug applications with a Competitive Generic...[ Price : $8.95]
FDA announces a 9/17 Vaccines and Related Biological Products Advisory Committee meeting to discuss Pfizer-BioNTechs supplemental ...[ Price : $8.95]
FDA approves Janssens Invega Hafyera six-month atypical antipsychotic injection for some adult schizophrenia patients.